{"database": "openregs", "table": "documents", "rows": [["FDA-2013-N-1523-0001", "FDA", "FDA-2013-N-1523", "Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Request for Nominations", "Proposed Rule", "Request for Information", "2013-12-04T05:00:00Z", 2013, 12, "2013-12-04T05:00:00Z", "2014-03-05T04:59:59Z", "2014-03-11T01:02:11Z", "2013-28980", 0, 0, "09000064814a61e6"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2013-N-1523-0001"], "units": {}, "query_ms": 0.3908980288542807, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}